Susquehanna Advisors Group Inc. Acquires Shares of 74,219 The Chemours Company (NYSE:CC)

Susquehanna Advisors Group Inc. purchased a new position in shares of The Chemours Company (NYSE:CC - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 74,219 shares of the specialty chemicals company's stock, valued at approximately $1,254,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in Chemours by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 15,223,961 shares of the specialty chemicals company's stock valued at $257,285,000 after purchasing an additional 94,885 shares in the last quarter. Geode Capital Management LLC boosted its stake in Chemours by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 2,491,748 shares of the specialty chemicals company's stock worth $50,646,000 after buying an additional 28,803 shares during the last quarter. Norges Bank purchased a new stake in Chemours in the 4th quarter valued at about $30,702,000. Dimensional Fund Advisors LP increased its stake in shares of Chemours by 22.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,779,702 shares of the specialty chemicals company's stock valued at $30,077,000 after acquiring an additional 328,414 shares during the last quarter. Finally, American Century Companies Inc. lifted its holdings in shares of Chemours by 7.6% during the 4th quarter. American Century Companies Inc. now owns 1,625,019 shares of the specialty chemicals company's stock worth $27,463,000 after acquiring an additional 115,436 shares during the period. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently commented on CC. The Goldman Sachs Group dropped their price target on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating for the company in a research report on Tuesday, January 7th. Mizuho set a $15.00 target price on Chemours in a research report on Tuesday, April 15th. Barclays dropped their price target on Chemours from $19.00 to $16.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 1st. BMO Capital Markets dropped their target price on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a research report on Wednesday, February 19th. Finally, Morgan Stanley reduced their price target on shares of Chemours from $25.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Monday, January 13th. Four research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $21.56.

Chemours Stock Down 0.6 %

CC traded down $0.08 during trading hours on Friday, reaching $12.36. 1,658,033 shares of the stock traded hands, compared to its average volume of 1,864,138. The Chemours Company has a fifty-two week low of $9.33 and a fifty-two week high of $29.21. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92. The company has a market cap of $1.85 billion, a price-to-earnings ratio of 21.68 and a beta of 1.84. The firm's fifty day simple moving average is $13.41 and its two-hundred day simple moving average is $17.12.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The business had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.37 billion. As a group, analysts forecast that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were paid a $0.25 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.09%. Chemours's dividend payout ratio (DPR) is presently 175.44%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.